High‐dose Methotrexate plus temozolomide with or without rituximab in patients with untreated primary central nervous system lymphoma: A retrospective study from China-Reference-Cited by-同舟云学术

High‐dose Methotrexate plus temozolomide with or without rituximab in patients with untreated primary central nervous system lymphoma: A retrospective study from China

Published:2019-03 Issue:4 Volume:8 Page:1359-1367
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Chen Cui¹²³,Sun Peng¹²,Cui Juan⁴,Yan Shumei²⁵,Chen Hao²⁶,Xia Yi¹²,Bi Xiwen¹²,Liu Panpan¹²^ORCID,Wang Yu¹²,Yang Hang¹²,Nie Man¹²,Zhang Xue‐Wen¹²,Jiang Wenqi¹²^ORCID,Li Zhi‐Ming¹²

Affiliation:

1. Department of Medical OncologySun Yat‐Sen University Cancer Center Guangzhou China

2. State Key Laboratory of Oncology in South ChinaCollaborative Innovation Center for Cancer Medicine Guangzhou China

3. Department of Oncology, the First Affiliated HospitalSun Yat‐Sen University Guangzhou China

4. Ward One, Department of ChemotherapyWuzhou Red Cross Hospital Wuzhou China

5. Department of PathologySun Yat‐Sen University Cancer Center Guangzhou China

6. Department of Clinical Laboratory MedicineSun Yat‐Sen University Cancer Center Guangzhou China

Funder

Natural Science Foundation of Guangdong Province

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.1906

Reference37 articles.

1. Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment

2. Therapy of primary cns lymphoma: role of intensity, radiation, and novel agents;Ajm F;Hematology Am Soc Hematol Educ Program,2017

3. Pharmacotherapy for Primary CNS Lymphoma

4. Primary lymphoma of brain: results of management of a modern cohort with radiation therapy

5. Analysis of Radiotherapy in 1054 Patients with Primary Central Nervous System Lymphoma Treated from 1985 to 2009

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Specific KIR-HLA genotypes predict outcomes in refractory or relapsed primary central nervous system lymphoma;Hematology;2023-08-07

2. A cerebral lymphoma mimicking a meningioma: case report;Annals of Medicine & Surgery;2023-08-04

3. Rituximab with high-dose methotrexate is effective and cost-effective in newly diagnosed primary central nervous system lymphoma;Scientific Reports;2022-12-13

4. Specific KIR-HLA genotypes predict the outcomes of refractory or recurrent primary central nervous system lymphoma;2022-10-11

5. Orelabrutinib Combined With Lenalidomide and Immunochemotherapy for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Retrospective Analysis of Case Series;Frontiers in Oncology;2022-06-16